Home/Contractors/Childrens Hospital Medical Center/contracts

Federal Contractor Profile

Childrens Hospital Medical Center

$34.6M obligated·69 awards·2 agencies·12 NAICS

Federal Contracts

Showing contracts 5195 of 95 total. Sorted by action date, most recent first. Excludes $0 modifications.

DateAgencyPIIDNAICSDescriptionAmount
Apr 3, 2019Department of Health and Human ServicesNATIONAL INSTITUTES OF HEALTH NIAID75N93018F00019541712VACCINE AND TREATMENT EVALUATION UNITS (VTEU) OVERALL ADMINISTRATION, CLINICAL OPERATIONS SUPPORT AND CONCEPT AND PROTOCOL DEVELOPMENT, IMPLEMENTATION AND ASSAYS TASK AREA A-D TASK ORDER FY.2019.A1B1C1D1.0103$2.7M
Nov 14, 2018Department of Health and Human ServicesNATIONAL INSTITUTES OF HEALTH NIAIDHHSN27200009541712IGF::OT::IGF PROTOCOL DEVELOPMENT(BASE) AND PROTOCOL IMPLEMENTATION(OPTIONS 1-6) RELATIVE TO PROTOCOL 14-0112, A PHASE II DOUBLE-BLIND RANDOMIZED PLACEBO CONTROLLED TRIAL TO EVALUATE THE SAFETY, REACTOGENICITY, AND IMMUNOGENICITY OF ONE OR TWO DOSES OF M-001 FOLLOWED BY ONE OR TWO DOSES OF AN INFLUENZA A/H7N9 VACCINE IN HEALTHY VOLUNTEERS.$195K
Oct 24, 2018Department of Health and Human ServicesNATIONAL INSTITUTES OF HEALTH NIAIDHHSN27200003541711TO ISSUE TASK ORDER A-05, "MOUSE AND GUINEA PIG MODELS FOR CYTOMEGALOVIRUS AND HERPES SIMPLEX VIRUSES."$738K
Oct 15, 2018Department of Health and Human ServicesNATIONAL INSTITUTES OF HEALTH NIAID75N93019F000965417121300016I CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER; TO 18-0011.B1C1.0116--16 BASE TASK ORDER FUNDING; BIOD CAN 8470038 $140,362$140K
Sep 17, 2018Department of Health and Human ServicesNIH NCI75N91018P00738621511PRODUCTION AND BIOSAFETY TESTING OF CGMP (CURRENT GOOD MANUFACTURING PRACTICES) - COMPLIANT TRANSIENT GAMMARETROVIRAL VECTOR FOR NCI CLINICAL TRIALS.$217K
Sep 11, 2018Department of Health and Human ServicesCDC OFFICE OF ACQUISITION SERVICES75D30118F00010621399IGF::OT::IGF CISA CHILDERN'S HOSPITAL MEDICAL CENTER$613K
Sep 7, 2018Department of Health and Human ServicesCDC OFFICE OF ACQUISITION SERVICESHHSD2002012536610007621399IGF::OT::IGF CISA CHILDERN'S HOSPITAL MEDICAL CENTER$230K
Aug 21, 2018Department of Health and Human ServicesCDC OFFICE OF ACQUISITION SERVICESHHSD2002012536610008621399IGF::OT::IGF CISA CHILDERN'S HOSPITAL MEDICAL CENTER$42K
Jul 31, 2018Department of Health and Human ServicesNATIONAL INSTITUTES OF HEALTH NIDA75N95018P00448621511CHILDREN''S HOSPITAL MEDICAL CTR:1107000 [18-000339]$9K
Jul 27, 2018Department of Health and Human ServicesNATIONAL INSTITUTES OF HEALTH NIAIDHHSN27200016541712IGF::OT::IGF VACCINE AND TREATMENT EVALUATION UNITS (VTEU)PROTOCOL DEVELOPMENT, IMPLEMENTATION AND ASSAYSTASK AREA B-D PHASE 1 VACCINE TRIAL FOR EBOLA VIRUS TASK ORDER 14-0092.B1C1D1.0061$94K
Jul 3, 2018Department of Health and Human ServicesCDC OFFICE OF ACQUISITION SERVICESHHSD2002012536610004621399IGF::OT::IGF CISA CHILDERN'S HOSPITAL MEDICAL CENTER$4K
Jun 19, 2018Department of Health and Human ServicesNATIONAL INSTITUTES OF HEALTH NIAID75N93018F00019541712VACCINE AND TREATMENT EVALUATION UNITS (VTEU) OVERALL ADMINISTRATION, CLINICAL OPERATIONS SUPPORT AND CONCEPT AND PROTOCOL DEVELOPMENT, IMPLEMENTATION AND ASSAYS TASK AREA A-D TASK ORDER FY.2019.A1B1C1D1.0103$395K
May 24, 2018Department of Health and Human ServicesNATIONAL INSTITUTES OF HEALTH NIAIDHHSN27200014541712IGF::OT::IGF AWARD OF VACCINE AND TREATMENT EVALUATION UNITS (VTEU)$71K
Apr 16, 2018Department of Health and Human ServicesNATIONAL INSTITUTES OF HEALTH NIAIDHHSN27200014541712IGF::OT::IGF AWARD OF VACCINE AND TREATMENT EVALUATION UNITS (VTEU)$141K
Feb 27, 2018Department of Health and Human ServicesNATIONAL INSTITUTES OF HEALTH NIAIDHHSN27200014541712IGF::OT::IGF AWARD OF VACCINE AND TREATMENT EVALUATION UNITS (VTEU)$141K
Feb 14, 2018Department of Health and Human ServicesNATIONAL INSTITUTES OF HEALTH NIAIDHHSN27200018541712VACCINE AND TREATMENT EVALUATION UNITS (VTEU) PROTOCOL IMPLEMENTATION TASK AREA C PHASE I STUDY TO EVALUATE THE PHARMACOKINETICS OF PLAZOMICIN IN ADOLESCENTS, CHILDREN AND INFANTS TASK ORDER 16-0047.C1.0090$308K
Nov 1, 2017Department of Health and Human ServicesNATIONAL INSTITUTES OF HEALTH NIAIDHHSN27200003541711TO ISSUE TASK ORDER A-05, "MOUSE AND GUINEA PIG MODELS FOR CYTOMEGALOVIRUS AND HERPES SIMPLEX VIRUSES."$737K
Oct 19, 2017Department of Health and Human ServicesNATIONAL INSTITUTES OF HEALTH NIAIDHHSN27200002541711PURPOSE: TO ISSUE TASK A-08 IN THE AMOUNT OF $5,433 FOR THE "BASE IDIQ KICK-OFF MEETING."$5K
Sep 23, 2017Department of Health and Human ServicesCDC OFFICE OF ACQUISITION SERVICESHHSD2002012536610008621399IGF::OT::IGF CISA CHILDERN'S HOSPITAL MEDICAL CENTER$39K
Sep 21, 2017Department of Health and Human ServicesNATIONAL INSTITUTES OF HEALTH NIAIDHHSN27200014541712IGF::OT::IGF AWARD OF VACCINE AND TREATMENT EVALUATION UNITS (VTEU)$1.3M
Sep 20, 2017Department of Health and Human ServicesNATIONAL INSTITUTES OF HEALTH NIAIDHHSN27200017541712IGF::OT::IGF VACCINE AND TREATMENT EVALUATION UNITS (VTEU) ASSAY TASK AREA D PHASE 1 VACCINE TRIAL FOR RSV TASK ORDER 16-0108.D1.0084$125K
Sep 19, 2017Department of Health and Human ServicesCDC OFFICE OF ACQUISITION SERVICESHHSD2002012536610007621399IGF::OT::IGF CISA CHILDERN'S HOSPITAL MEDICAL CENTER$104K
Sep 18, 2017Department of Health and Human ServicesCDC OFFICE OF ACQUISITION SERVICESHHSD2002012536610009621399IGF::OT::IGF CISA CHILDERN'S HOSPITAL MEDICAL CENTER TDAP CONTRIBUTING$146K
Sep 15, 2017Department of Health and Human ServicesNATIONAL INSTITUTES OF HEALTH NIAIDHHSN27200011541712IGF::OT::IGF VACCINE AND TREATMENT EVALUATION UNITS$290K
Aug 18, 2017Department of Health and Human ServicesNATIONAL INSTITUTES OF HEALTH NIAIDHHSN27200016541712IGF::OT::IGF VACCINE AND TREATMENT EVALUATION UNITS (VTEU)PROTOCOL DEVELOPMENT, IMPLEMENTATION AND ASSAYSTASK AREA B-D PHASE 1 VACCINE TRIAL FOR EBOLA VIRUS TASK ORDER 14-0092.B1C1D1.0061$2.9M
Aug 11, 2017Department of Health and Human ServicesNIH NCIHHSN261201700263P325414IGF::OT::IGF THE CONTRACTOR SHALL PRODUCE 20 LITERS OF CLINICAL-GRADE GAMMA-RETROVIRAL GENE-THERAPY VECTOR FOR USE IN A CLINICAL TRIAL. THIS GAMMA-RETROVIRAL GENE-THERAPY VECTOR WILL BE PRODUCED BY THE TRANSIENT TRANSFECTION METHOD, AND THE VECTOR MUST BE COMPLETED BY THE END OF 2017. THE VECTOR WILL ENCODE A CHIMERIC ANTIGEN RECEPTOR (CAR) RECOGNIZING A MULTIPLE MYELOMA ANTIGEN. THE INTENDED USE OF THIS VECTOR IS TO TRANSDUCE PATIENT T CELLS. THESE T CELLS WILL BE ADMINISTERED AS A TREATMENT FOR MULTIPLE MYELOMA IN A CLINICAL TRIAL. THE VECTOR WILL BE GIBBON APE LEUKEMIA VIRUS (GALV) PSEUDOTYPED. THE VECTOR WILL BE GENERATED IN 293T CELLS. THE CONTRACTOR WILL PROVIDE PACKAGING PLASMIDS. THE NCI WILL PROVIDE A PLASMID ENCODING THE CAR ALSO KNOWN AS THE EXPRESSION CONSTRUCT.$258K
Jul 26, 2017Department of Health and Human ServicesNATIONAL INSTITUTES OF HEALTH NIAIDHHSN27200015541712IGF::OT::IGF VACCINE AND TREATMENT EVALUATION UNITS (VTEU) PROTOCOL DEVELOPMENT AND IMPLEMENTATION TASK AREA B-C PHASE II VACCINE TRIAL FOR INFLUENZA TASK ORDER$5.6M
Jul 12, 2017Department of Health and Human ServicesNATIONAL INSTITUTES OF HEALTH NIAIDHHSN27200014541712IGF::OT::IGF AWARD OF VACCINE AND TREATMENT EVALUATION UNITS (VTEU)$298K
Jul 10, 2017Department of Health and Human ServicesNATIONAL INSTITUTES OF HEALTH NIAIDHHSN27200013541712IGF::OT::IGF AWARD OF VACCINE AND TREATMENT EVALUATION UNITS (VTEU)$2.9M
Jun 13, 2017Department of Health and Human ServicesNATIONAL INSTITUTES OF HEALTH NIAIDHHSN27200006541712IGF::OT::IGF TO 06 14-0079.B1C1.0028--16$243K
May 26, 2017Department of Health and Human ServicesNATIONAL INSTITUTES OF HEALTH NIAIDHHSN27200012541712IGF::OT::IGF VACCINE AND TREATMENT EVALUATION UNITS$1.3M
Mar 23, 2017Department of Health and Human ServicesNATIONAL INSTITUTES OF HEALTH NIAIDHHSN272200800006C541711BIOMEDICAL (APPLIED/EXPLORATORY)$3.2M
Nov 17, 2016Department of Health and Human ServicesNATIONAL INSTITUTES OF HEALTH NIAIDHHSN27200010541712IGF::OT::IGF OVERALL ADMINISTRATION, CLINICAL OPERATIONS SUPPORT AND CONCEPT AND PROTOCOL DEVELOPMENT, IMPLEMENTATION AND ASSAYS$176K
Sep 22, 2016Department of Health and Human ServicesCDC OFFICE OF ACQUISITION SERVICESHHSD200201691939C541712IGF::OT::IGF METAGENOMIC PREDICTORS$643K
Sep 20, 2016Department of Health and Human ServicesNATIONAL INSTITUTES OF HEALTH NIAIDHHSN27200009541712IGF::OT::IGF PROTOCOL DEVELOPMENT(BASE) AND PROTOCOL IMPLEMENTATION(OPTIONS 1-6) RELATIVE TO PROTOCOL 14-0112, A PHASE II DOUBLE-BLIND RANDOMIZED PLACEBO CONTROLLED TRIAL TO EVALUATE THE SAFETY, REACTOGENICITY, AND IMMUNOGENICITY OF ONE OR TWO DOSES OF M-001 FOLLOWED BY ONE OR TWO DOSES OF AN INFLUENZA A/H7N9 VACCINE IN HEALTHY VOLUNTEERS.$512K
Sep 19, 2016Department of Health and Human ServicesNATIONAL INSTITUTES OF HEALTH NIAIDHHSN27200011541712IGF::OT::IGF VACCINE AND TREATMENT EVALUATION UNITS$763K
Sep 16, 2016Department of Health and Human ServicesCDC OFFICE OF ACQUISITION SERVICESHHSD2002012536610002621399IGF::OT::IGF CISA CLINICAL CONSULT ACTIVITY$39K
Sep 14, 2016Department of Health and Human ServicesCDC OFFICE OF ACQUISITION SERVICESHHSD2002012536610003621399IGF::OT::IGF CISA CHILDERN'S HOSPITAL MEDICAL CENTER$199K
Sep 13, 2016Department of Health and Human ServicesCDC OFFICE OF ACQUISITION SERVICESHHSD2002012536610006621399IGF::OT::IGF CISA CHILDERN'S HOSPITAL MEDICAL CENTER$141K
Jul 18, 2016Department of Health and Human ServicesNATIONAL INSTITUTES OF HEALTH NIAIDHHSN27200010541712IGF::OT::IGF OVERALL ADMINISTRATION, CLINICAL OPERATIONS SUPPORT AND CONCEPT AND PROTOCOL DEVELOPMENT, IMPLEMENTATION AND ASSAYS$338K
Jul 12, 2016Department of Health and Human ServicesNATIONAL INSTITUTES OF HEALTH NIAIDHHSN27200003541711IGF::OT::IGF R&D- MEDICAL: BIOMEDICAL (BASIC RESEARCH)$754K
Jun 28, 2016Department of Health and Human ServicesNIH NCIHHSN261201600428P621511CINCINNATI CHILDREN'S HOSPITAL [16-043336] IGF::CL::IGF$8K
Mar 25, 2016Department of Health and Human ServicesNIH, NIAID DEA OA OFC ACQUISITIONSHHSN27200006541712IGF::OT::IGF TO 06 14-0079.B1C1.0028--16$169K
Jan 13, 2016Department of Health and Human ServicesNIH, NIAID DEA OA OFC ACQUISITIONSHHSN27200009541712IGF::OT::IGF PROTOCOL DEVELOPMENT(BASE) AND PROTOCOL IMPLEMENTATION(OPTIONS 1-6) RELATIVE TO PROTOCOL 14-0112, A PHASE II DOUBLE-BLIND RANDOMIZED PLACEBO CONTROLLED TRIAL TO EVALUATE THE SAFETY, REACTOGENICITY, AND IMMUNOGENICITY OF ONE OR TWO DOSES OF M-001 FOLLOWED BY ONE OR TWO DOSES OF AN INFLUENZA A/H7N9 VACCINE IN HEALTHY VOLUNTEERS.$90K
Oct 19, 2015Department of Health and Human ServicesNIH, NIAID DEA OA OFC ACQUISITIONSHHSN27200008541712IGF::OT::IGF; 1300016I TO 0008-15-0064.C1.0039 INFLUENZA A/H5N8 VIRUS VACCINE TRIAL; BIOD CAN 8470038; $617,036 POP 10/19/2015 THROUGH 10/15/2017$617K

Get Alerted Before Childrens Hospital Medical Center's Next Recompete

Mindy monitors active contracts and flags recompetes 12 months out so you can position to compete.

Start Free